RNU6-947P

Across TCGA pan-cancer cohorts, RNU6-947P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-947P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-947P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-947P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCEC, ACC, and CHOL are the cancer types where RNU6-947P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.435	0.841	<.001	108	view →
ACC	OS	Tertile	All	0.113	0.822	<.001	63	view →
CHOL	DFS	Tertile	All	0.045	0.497	.029	36	view →
KIRC	DFS	Tertile	IV	0.204	0.623	.011	36	view →
KIRP	OS	Tertile	All	0.135	0.703	.002	27	view →
UVM	DFS	Tertile	All	0.180	0.744	.019	18	view →
ESCA	OS	Tertile	III,IV	0.769	0.372	.036	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-947P–UCEC (DFS)

Open the UCEC breakdown →